N-methyl-N-(1-(2-((2-methoxyphenyl)amino)benzoyl)piperidin-4-yl)-2-trifluoromethyl-4-fluoro-benzamide

ID: ALA4635021

PubChem CID: 156014249

Max Phase: Preclinical

Molecular Formula: C28H27F4N3O3

Molecular Weight: 529.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccccc1Nc1ccccc1C(=O)N1CCC(N(C)C(=O)c2ccc(F)cc2C(F)(F)F)CC1

Standard InChI:  InChI=1S/C28H27F4N3O3/c1-34(26(36)20-12-11-18(29)17-22(20)28(30,31)32)19-13-15-35(16-14-19)27(37)21-7-3-4-8-23(21)33-24-9-5-6-10-25(24)38-2/h3-12,17,19,33H,13-16H2,1-2H3

Standard InChI Key:  SUGACIRRQDVQFQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
    5.5029  -12.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3282  -12.8249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7422  -12.1113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3278  -11.3960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4993  -11.3988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0933  -12.1130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0917  -13.5407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7433  -13.5420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3271  -14.2544    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5704  -13.5427    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9777  -14.2572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8012  -14.2599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2213  -13.5493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8075  -12.8303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9777  -12.8260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0484  -13.5530    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4566  -14.2676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4631  -12.8381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0418  -14.9826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2837  -14.2713    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2168  -14.9759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7980  -15.6901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2104  -16.4097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0418  -16.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4527  -15.6961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2687  -13.5429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8580  -12.8305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0359  -12.8324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6255  -13.5467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0433  -14.2606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8642  -14.2552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7973  -17.1215    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.2757  -15.6959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6874  -16.4084    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.6869  -14.9830    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.0949  -15.6943    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.2805  -14.9650    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8739  -15.6805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  2  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  1  0
 16 18  1  0
 17 19  1  0
 17 20  2  0
 19 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 19  1  0
  7 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 23 32  1  0
 25 33  1  0
 33 34  1  0
 33 35  1  0
 33 36  1  0
 31 37  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4635021

    ---

Associated Targets(Human)

SMO Tclin Smoothened homolog (1371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Daoy (570 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2058 (690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 529.53Molecular Weight (Monoisotopic): 529.1989AlogP: 5.97#Rotatable Bonds: 6
Polar Surface Area: 61.88Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 5.98CX LogD: 5.98
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.40Np Likeness Score: -1.48

References

1. Ji D, Zhang W, Xu Y, Zhang JJ..  (2020)  Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors.,  28  (6): [PMID:32063403] [10.1016/j.bmc.2020.115354]

Source